|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| In utero exposure to steroid contraceptives and outcome of pregnancy. |
| AMERICAN JOURNAL OF EPIDEMIOLOGY. 1991 Oct 15;134(8):795-803. |
| A cohort study of women who used steroid contraceptives during pregnancy was conducted in Chiang Mai, northern |
| Thailand, between 1984-1987. There were 1573 pregnancies in which the fetus was exposed to the injectable |
| contraceptive Depo-Provera (Upjohn Company, Kalamazoo, Michigan). 830 accidental pregnancies and 743 infants |
| conceived before the mother began using Depo-Provera were noted, 601 accidental pregnancies occurred in women |
| who used oral contraceptives (OCs), and 2578 planned pregnancies occurred with no steroid exposures (controls). |
| Subjects were followed for interview, and medical records were traced for birthweight. Women using Depo-Provera |
| had more risk factors for adverse pregnancy outcomes than did the other groups. The adjusted odds ratios (OR) for |
| low birthweight were increased for accidental pregnancies with fetal exposure to Depo-Provera (OR=1.5, 95% |
| confidence interval [CI] 1.2-1.9) or OCs (OR=1.5, 05% CI 1.2-2.0). The higher risk of low birthweight among infants |
| exposed in utero to Depo-Provera or OCs is due in part to self-selection for adverse outcomes among women with |
| unplanned pregnancies. However, among accidental pregnancies with Depo-Provera, the risk of low birthweight was |
| significantly increased when conception was estimated to have occurred within 4 weeks of injection. The ORs were |
| 1.9 (95% CI 1.4-3.2) for injection-to-conception intervals of <or= 4 weeks, 1.5 (95% CI 0.9-2.3) for intervals of 5-8 |
| weeks, and 1.2 (95% CI 0.7-1.9) for intervals of >or= 9 weeks. This trend was highly significant. The authors thus |
| conclude that early, high-dose in utero exposures to Depo-Provera may affect fetal growth. (author's) (PubHealth.info |
| Document ID: CONT3T 2031-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "In utero exposure to steroid contraceptives and outcome of |
| pregnancy.", is(are) Pardthaisong T; Gray RH. The source of this article is "AMERICAN JOURNAL OF |
| EPIDEMIOLOGY. 1991 Oct 15;134(8):795-803.". This article was published in 1991 in English language(s). |
| (PubHealth.info® Document ID: CONT3T 2031-06. All rights reserved with PubHealth.info) PIN: 12031 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
